Gunilla Osswald
Tracked across 5 events · 32 articles · First seen Apr 21, 2026 · Last active Sep 22, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Gunilla Osswald, CEO of BioArctic, will present and comment on the first quarter report during the webcast and teleconference.
May 13, 2026 · 7 articles
Business
Impact: As CEO of BioArctic, Gunilla Osswald announced the collaboration, representing BioArctic's strategic move into oncology.
Aug 19, 2026 · 6 articles
Tech
BioArctic announced that Leqembi (lecanemab), the first therapy targeting an underlying cause of Alzheimer's disease, is now available at a private clinic in Sweden and that the first patient has started treatment. This marks the…
Impact: Gunilla Osswald, CEO of BioArctic, commented on the significance of bringing Leqembi to Swedish patients and highlighted the unmet need in early Alzheimer's disease.
Sep 22, 2026 · 7 articles
Business
Impact: CEO Gunilla Osswald will present the Q2 results during the webcast. Her role is standard for an earnings call.
Aug 19, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Gunilla Osswald live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard